11/20/2014 - 10:42am

Dr. Reddy’s Labs announced Thursday that it has launched a bioequivalent generic version of Allegra-D 12 Hour Allergy and Congestion, in the U.S. market.

11/20/2014 - 9:51am

Decision Resources Group found that sales of biosimilar versions of the granulocyte colony-stimulating factors (G-CSFs) filgrastim and pegfilgrastim could reach $1.8 billion in the United States by 2023. 

11/20/2014 - 9:13am

More specialty drug innovation, greater patient access to medicines and reduced impact from patent expiries will be the primary drivers of an increase in global medicine spending of up to 30% by 2018.

11/19/2014 - 9:59am

The Food and Drug Administration opened a public docket and requested comments on proposed criteria for “first generic” abbreviated new drug application submissions.

 

11/19/2014 - 5:37am

Nearly eight in 10 Americans (78%) would consider seeing a healthcare professional virtually for at least one healthcare need, according to a new Harris Poll.

11/18/2014 - 2:28pm

Teva Canada Limited, a subsidiary of Teva Pharmaceutical Industries, on Tuesday announced that Health Canada has approved its application for PrTeva-Celecoxib, the generic equivalent of PrCelebrex.

11/18/2014 - 1:21pm

Camber Pharmaceuticals on Monday announced their selection as a 2014 “Supplier of the Year” at Anda’s annual Supplier Strategy Meeting in Doral, Fla.

11/17/2014 - 6:46pm

Drug Store News caught up with Upsher-Smith chief commercial officer Rusty Field to discuss topiramate extended-release capsules, its new authorized generic to Qudexy XR.

11/17/2014 - 6:45pm

DSN spoke with Neas in late October to mark the 30th anniversary of the landmark Drug Price Competition and Patent Term Restoration Act — better known as the Hatch-Waxman Act.